Advertisement
Screener

ARMATA PHARMACEUTICALS, INC. (ARMP) Deferred Tax Liabilities, Gross

2.8 / 5 stars · 68/120 Roast Me

ARMATA PHARMACEUTICALS, INC. Deferred Tax Liabilities, Gross

ARMATA PHARMACEUTICALS, INC. (ARMP) had Deferred Tax Liabilities, Gross of $12.38 million as of 2025-12-31, per its 10-K filed 2026-03-25.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net

us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-25

  • 2025-12-31: Deferred Tax Liabilities, Gross $12.38M.
  • 2024-12-31: Deferred Tax Liabilities, Gross $15.97M.
  • 2023-12-31: Deferred Tax Liabilities, Gross $14.68M; Deferred Tax Liabilities, Gross as first filed $14.68K.
  • 2022-12-31: Deferred Tax Liabilities, Gross $15.12K; Deferred Tax Liabilities, Gross as first filed $15.12M.
Period endDeferred Tax Liabilities, GrossDeferred Tax Liabilities, Gross as first filed
2025-12-31$12.38M
10-K · filed 2026-03-25
2024-12-31$15.97M
10-K · filed 2026-03-25
2023-12-31$14.68M
10-K · filed 2025-03-21
$14.68K
10-K · filed 2024-03-21
2022-12-31$15.12K
10-K · filed 2024-03-21
$15.12M
10-K · filed 2023-03-16
2021-12-31$13.11M
10-K · filed 2023-03-16
2020-12-31$6.10M
10-K · filed 2022-03-17
2019-12-31$3.73M
10-K · filed 2021-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22